Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Macrolide; protein translation inhibitor.
NSAID; COX-1/2 inhibitor.
GSK-3β, HGK, and CDK inhibitor.
Aromatase inhibitor.
Aldose reductase inhibitor.
p110α and p110γ PI3K inhibitor.
5-fluorouracil prodrug, pyrimidine analog; thym...
STING agonist
β-lactamase inhibitor.
FLT3, PDGFR inhibitor.
β2-adrenergic agonist, BChE inhibitor.
Natriuretic, vasodilatory peptide fragment; B1/...
Cdc7 inhibitor.
Triterpene saponin found in Bupleurum.
Fluoroquinolone; bacterial DNA gyrase and helic...
ITC found in cruciferous vegetables; HDAC inhib...
NSAID; COX-1/2 inhibitor.
May induce apoptosis in lymphoma cell lines.
β-lactam; penicillin binding protein inhibitor...
Fluoroquinolone; topoisomerase IV and bacterial...